Medication compliance in mood disorders: Relevance of the Health Belief Model and other determinants

Primary Care Psychiatry

Volumn 6, Issue 3, 2000, Pages 101-110

  Cohen, N L ^a,b   Parikh, S V ^c   Kennedy, S H ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b YORK UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adherence; Antidepressants; Attitudes; Bipolar disorder; Depression; Health belief model; Medication non compliance

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM; NEUROLEPTIC AGENT;

AFFECTIVE NEUROSIS; DEPRESSION; DISEASE COURSE; DISEASE MARKER; DOCTOR PATIENT RELATION; HEALTH CARE COST; HUMAN; MAINTENANCE THERAPY; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RESEARCH; MENTAL DISEASE; MODEL; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

EID: 0033668372     PISSN: 13552570     EISSN: None     Source Type: Journal    
DOI: 10.1185/135525700543307     Document Type: Review

References (85)

1. Compliance therapy in psychotic patients: Randomized controlled trial
2. Health economics and cost implications of anxiety and other mental disorders in the United States
3. The economic burden of depression in 1990
4. Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression
5. Compliance: Definitions and key issues
6. Compliance in depressed patients treated with fluoxetine or amitriptyline
7. Promoting therapeutic alliance and adherence to medication treatment in depression
8. Alliance not compliance: A philosophy of outpatient care
9. The role of the primary care physician in patients' adherence to antidepressant therapy
10. Compliance in clinical trials
11. The content and context of compliance
12. Compliance
13. Compliance during treatment with antidepressants
14. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder
15. Ratings of medication influences (ROMI) scale in schizophrenia
16. Consistency of adherence across regimen demands
17. Compliance with pharmacotherapy in adolescents: Effects of patients' and parents' knowledge and attitudes toward treatment
18. Construct validity comparisons of three methods for measuring patient compliance
19. Time to stop counting the tablets?
20. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression
21. Monitoring compliance with antiepileptic drug therapy
22. Overview of methods to measure and enhance patient compliance
23. Optimizing long-term patient compliance
24. Effect of compliance for chronic asthmatic children
25. A riboflavin tracer method for assessment of medication compliance in children
26. Behavioral control of medicine compliance
27. Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics
28. How often is medication taken as prescribed? A novel assessment technique
29. Partial compliance: Implication for clinical practice
30. Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study
31. Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug
32. Clinical correlates of antidepressant compliance
33. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
34. Neuroleptic noncompliance in schizophrenia
35. Subjective response as a predictor of outcome in pharmacotherapy: The consumer has a point
36. Subjective response to antipsychotic drugs
37. A self-report predictive of drug compliance in schizophrenics: Reliability and discriminative validity
38. Awareness of illness in schizophrenia and outpatient treatment adherence
39. Patients' subjective experiences on antipsychotic medications: Implication for outcome and quality of life
40. Drug therapy in schizophrenia - Variability of outcome and prediction of response
41. Failure to have prescriptions filled among Black elderly
42. A two-year prospective study of treatment compliance in patients with schizophrenia
43. Why people use health services
44. Sociobehavioral determinants of compliance with health and medical care recommendations
45. Noncompliance in schizophrenia
46. Clinical characteristics, health beliefs and compliance with maintenance treatment: A comparison between regular and irregular attenders at a depot clinic
47. Assessment of compliance-related attitudes in psychiatry: A comparison of two questionnaires based on the Health Belief Model
48. Utility of the health belief model in examining medication compliance among psychiatric outpatients
49. Adherence to treatment regimen in a lithium carbonate clinic
50. Compliance in psychiatry: Development of a patient questionnaire
51. ZurDefinition, bedeutung und messung der krankheitskonzepte von patienten. Die krankheitskonxeptskala (KK-Skala) fur schizophrene patienten
52. Compliance with medication regimens for mental and physical disorders
53. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis
54. Patients with a low income have a reduced renal allograft survival
55. The implications of noncompliance with antihypertensive medication
56. Compliance with cardiovascular disease prevention strategies: A review of the research
57. Lithium and recurrence in a long-term follow-up of bipolar affective disorder
58. Continuation drug therapy for major depressive episodes: How long should it be maintained?
59. Maintenance treatment
60. Residual symptoms after partial remission: An important outcome in depression
61. Adequacy and duration of antidepressant treatment in primary care
62. Factors associated with pharmacologic noncompliance in patients with mania
63. Compliance with maintenance treatment in bipolar disorder
64. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
65. Adherence to lithium prophylaxis: I. Clinical predictors and patients' reasons for nonadherence
66. Compliance with long-term lithium treatment in major affective disorders
67. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders
68. Long-term treatment of depression
69. The combat of non-compliance during prophylactic lithium treatment
70. Depression, disability days, and days lost from work in a prospective epidemiologic survey
71. Depression: A long-term illness
72. Antidepressant drugs: Side effects and compliance
73. Health behavior, illness behavior, and sick role behavior. I. Health and illness behavior
74. The problems of safety and compliance with conventional antidepressant drugs
75. A rating scale for depression
76. Adherence to lithium prophylaxis: II. Multivariate analysis of clinical social and psychosocial predictors of nonadherence
77. Patient and physician attitudes toward lithium
78. Out-patient compliance with antidepressant medication
79. Maintenance lithium treatment: Side effects and compliance
80. Attitudinal correlates of lithium compliance in bipolar affective disorders
81. Toward a Developmental Theory of Compliance